Janney Montgomery Scott LLC cut its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 40.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 507,363 shares of the financial services provider’s stock after selling 341,271 shares during the period. Janney Montgomery Scott LLC owned approximately 0.07% of MetLife worth $41,847,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in the company. Carmichael Hill & Associates Inc. grew its holdings in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Janney Capital Management LLC boosted its stake in MetLife by 1.9% during the third quarter. Janney Capital Management LLC now owns 40,390 shares of the financial services provider’s stock worth $3,331,000 after buying an additional 740 shares during the period. F M Investments LLC increased its position in shares of MetLife by 17.9% during the third quarter. F M Investments LLC now owns 98,418 shares of the financial services provider’s stock valued at $8,105,000 after acquiring an additional 14,976 shares during the last quarter. Chicago Partners Investment Group LLC purchased a new stake in shares of MetLife in the 3rd quarter valued at approximately $233,000. Finally, Farther Finance Advisors LLC lifted its holdings in shares of MetLife by 19.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 10,840 shares of the financial services provider’s stock worth $894,000 after acquiring an additional 1,774 shares during the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.
MetLife Stock Up 0.0 %
MetLife stock opened at $78.43 on Monday. The stock has a market cap of $54.93 billion, a PE ratio of 15.81, a P/E/G ratio of 0.66 and a beta of 1.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.16 and a quick ratio of 0.16. The stock’s fifty day moving average is $80.59 and its two-hundred day moving average is $74.92. MetLife, Inc. has a 1-year low of $58.89 and a 1-year high of $86.94.
MetLife Announces Dividend
Analyst Upgrades and Downgrades
MET has been the topic of a number of research analyst reports. TD Cowen began coverage on MetLife in a research report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 target price on the stock. Barclays decreased their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday. Bank of America dropped their target price on MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Piper Sandler increased their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Morgan Stanley dropped their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $88.38.
Read Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- High Flyers: 3 Natural Gas Stocks for March 2022
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Comparing and Trading High PE Ratio Stocks
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- The 3 Best Blue-Chip Stocks to Buy Now
- Battle of the Retailers: Who Comes Out on Top?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.